Réalité virtuelle dans la rééducation des fonctions exécutives chez les enfants atteints de trouble déficitaire de l'attention avec hyperactivité. (VREALFUN-ADHD)
Réalité Virtuelle en Rééducation des Fonctions Exécutives chez l'Enfant (VREALFUN)
Attention deficit hyperactivity disorder (ADHD) is caused by an abnormality in the development of the central nervous system. Children with attention and executive function difficulties often need long-lasting rehabilitation and there is an increasing need for timely, cost-effective, and feasible rehabilitation interventions, where the training is targeted to support everyday life functional capacity. The use of Virtual Reality (VR) in the rehabilitation of children with attention and executive function deficits offers opportunities to practice skills required in everyday life in environments emulating real-life situations.
The major aim of this research project is to develop a novel effective VR rehabilitation method for children with deficits in attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday life. In this randomized control study VR glasses are used to present the tasks, and the levels of difficulty are adjusted according to the child's progress.
Researchers expect that; 1) Intensive training improves the attention regulation, activity control skills and executive functions of the children in the intervention group; 2) Training of executive skills with motivating tasks in a virtual environment that is built to meet challenging everyday situations transfers to the child's everyday life, 3) The duration of the training effect does not depend on the success of the VR training itself, but on how well the child adopts new strategies that make everyday life easier and how the parent is able to support the child's positive behaviour in everyday life.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Merja Nikula, M.Psych.
- Numéro de téléphone: +3588315 5218
- E-mail: merja.nikula@pohde.fi
Sauvegarde des contacts de l'étude
- Nom: Johanna Uusimaa, MD, PhD
- E-mail: johanna.uusimaa@pohde.fi
Lieux d'étude
-
-
-
Oulu, Finlande, 90029
- Recrutement
- Oulu University Hospital
-
Contact:
- Johanna Uusimaa, MD, PhD
- E-mail: johanna.uusimaa@pohde.fi
-
Contact:
- Merja Nikula, M.Psych.
- E-mail: merja.nikula@pohde.fi
-
Chercheur principal:
- Merja Nikula, M.Psych.
-
Sous-enquêteur:
- Johanna Uusimaa, MD, PhD
-
Sous-enquêteur:
- Mirjami Mäntymaa, MD, PhD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Diagnosis of ADHD (ICD-10 F90.0) and
- Methylphenidate medication and
- Age 8-12 years and
- Finnish as a native language
Exclusion Criteria:
- Sensitivity to flashing light,
- Epilepsy (ICD-10 G40),
- Mental retardation (ICD-10 F70-F79),
- Pervasive developmental disorders (ICD-10 F84),
- Inflammatory diseases of the central nervous system (ICD-10 G00-G09),
- Severe cerebral palsy syndrome (ICD-10 G80, GMFCS 4-5, MACS 3-5),
- Traumatic brain injury ((ICD-10 S06),
- Brain tumour, and
- Multiple pregnancy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Conseil Parental+Jeu de Réalité Virtuelle
|
Parents get guidance for children's positive behaviour support by using parts of Self-Help Program on the MentalHub.fi (in Finnish: Mielenterveystalo.fi) website regarding children's challenging behaviour (in Finnish: Lasten haastavan käytöksen omahoito-ohjelma) .
Autres noms:
Virtual reality game for rehabilitation of attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday situations at home. |
|
Expérimental: Guidance parentale
|
Parents get guidance for children's positive behaviour support by using parts of Self-Help Program on the MentalHub.fi (in Finnish: Mielenterveystalo.fi) website regarding children's challenging behaviour (in Finnish: Lasten haastavan käytöksen omahoito-ohjelma) .
Autres noms:
|
|
Expérimental: Jeu de réalité virtuelle
|
Virtual reality game for rehabilitation of attention, activity control and executive functions by using the virtual environment that corresponds to the typical everyday situations at home. |
|
Aucune intervention: Control Group
This group implement the rehabilitation plan drawn up in specialized medical care (treatment as usual). |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Epeli (Executive Performance in Everyday LIving) task
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
A virtual reality task for attention, executive function, and prospective memory. Change in total score, task efficacy, navigation efficacy, controller motion, and total action. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
ADHD-rating scale IV (ADHD-RS) (parent report)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
The ADHD-RS (parent report) is an assessment of a child's ADHD symptoms with 18 items based on the child's behaviour over the past 6 months. 4-point Likert scale. The total score ranges 0-54, scores in inattention subscale and hyperactivity/impulsivity subscale range 0-27. Change in the total score, inattention subscale score, and hyperactivity/impulsivity subscale score on a parent-rated ADHD-RS. A lower score means a better outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Epeli Questionnaire (parent report)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks. 5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20. Change in Functional ability subscale score and Positive feedback subscale score on parent-rated Epeli- questionnaire. A higher score means a better outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Epeli Questionnaire (child report)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of a child's functional ability and the amount of positive feedback given by the parent to the child over the past 4 weeks. 5-point Likert scale. 2 subscales: Functional ability subscale where score ranges 4-20, and Positive feedback subscale where score ranges 4-20. Change in Functional ability subscale score and Positive feedback subscale score on child-rated Epeli- questionnaire. A higher score means a better outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Behavior Rating Inventory of Executive Function (BRIEF-2) (parent form)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
A measure of executive functions of children and adolescents in natural settings containing 63 items rated by the parent. 3-point Likert scale. Change in Global Executive Composite score, Behavior regulation score, Emotion regulation score, and Cognitive regulation score on parent-rated BRIEF-2. In case the data in the Behavior regulation, Emotion regulation, and Cognitive regulation subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on the BRIEF-2 Global Executive Composite score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected. A higher score means a worse outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Behavior Rating Inventory of Executive Function (BRIEF-2) (teacher form)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
A measure of executive functions of children and adolescents in natural settings containing 63 items rated by the teacher. 3-point Likert scale. Change in Global Executive Composite score, Behavior regulation score, Emotion regulation score, and Cognitive regulation score on teacher-rated BRIEF-2. In case the data in the Behavior regulation, Emotion regulation, and Cognitive regulation subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on the BRIEF-2 Global Executive Composite score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected. A higher score means a worse outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Concentration questionnaire (in Finnish: Keskittymiskysely)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of attention and executive function difficulties in school-aged children with 55 items. 3-point Likert Scale, Total score range 0-110. Change in Total score, Distractibility score (range 0-8), sum of Impulsivity and Motor hyperactivity subscales scores (range 0-32), sum of Directing, Sustaining and Shifting Attention subscales scores (range 0-30), and sum of Initiative, Planning, Execution and Evaluation of Action subscales scores (range 0-40) on teacher-rated Concentration questionnaire. In case the data in the Distractibility subscale, Impulsivity and Motor hyperactivity subscales, Attention subscales and Executive subscales are not too strongly correlated (r<0.7) and there will be a significant effect of the intervention on Concentration questionnaire Total score, we will use the subscales to conduct a post hoc analysis examining which domains of executive functions are affected. A higher score implies a worse outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version ( KINDL-R) (parent version)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of Health-Related Quality of Life in children and adolescents with 24 items. 5-point Likert scale. Change in Total score on parent-rated questionnaire. A higher score means a better outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
Questionnaire for Measuring Health-Related Quality of Life in Children and Adolescents Revised Version (KINDL-R) (self-report version)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
An assessment of Health-Related Quality of Life in children and adolescents with 24 items. 5-point Likert scale. Change in Total score on child-rated questionnaire. A higher score means a better outcome. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
N-back test
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
A test for a working memory. Change in 2-back and 1-back hitrate and reaction time. |
Baseline, 4-6 weeks, 6 months and 12 months.
|
|
The Conners Continuous Performance Test 3rd Edition (Conners CPT3)
Délai: Baseline, 4-6 weeks, 6 months and 12 months.
|
A computerized attention task validated in individuals aged 8 years and older. Change in scores on Conners Continuous Performance Test (CPT-3). |
Baseline, 4-6 weeks, 6 months and 12 months.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chaise d'étude: Johanna Uusimaa, MD, PhD, Oulu University Hospital
- Chercheur principal: Merja Nikula, M.Psych., Oulu University Hospital
- Directeur d'études: Mirjami Mäntymaa, MD, PhD, Oulu University Hospital
- Directeur d'études: Juha Salmitaival, PhD, University of Oulu, Finland
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 206/2021
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .